U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.

Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.

The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.


COVID-19 RESOURCES FOR HEALTHCARE PROFESSIONALS
 

Video Icon VACCINES AND THE ROLE OF MONOCLONAL ANTIBODY TREATMENT

Dr. Rachel Levine, Assistant Secretary for Health, discusses how clinicians should counsel their patients on monoclonal antibody treatment for COVID-19.

 

Early intervention with monoclonal antibody treatment may reduce the risk of severe illness and hospitalization for people with COVID-19 who are at high risk of developing more serious illness. Here are resources that can help you ensure rapid access to monoclonal antibody treatment for your high-risk COVID-19 patients.

Is your healthcare practice interested in being a study site for an ACTIV clinical trial? Please email [email protected] with the email subject, “Potential Site for ACTIV Trials."

 


SUPPORT TOOLS FOR CLINICIANS

Illustration of a doctor and a patient

TOOLS FOR YOUR PRACTICE

Identification and Referral

Download a brief guide to identifying and referring high-risk patients.

Download guide

Administering mAbs

Find a one-stop resource for guidance and instructions on preparing your facility, administering mAb treatments, and reporting therapeutic data and adverse events.

Download guide

Billing and Reimbursement

Learn about Medicaid, Medicare, and commercial insurance coverage for mAb treatment.

Download guide

Script

Download a script you can use to inform patients they have tested positive for COVID-19.

Download script

Illustration of a patient receiving a monoclonal antibody treatment

HELP YOUR PATIENTS UNDERSTAND mAb TREATMENTS

Patient FAQs

Read a Frequently Asked Questions (FAQ) document to help answer patient questions.

Download patient FAQs

Patient Flyer

Download "An Option for COVID-19 Positive Patients: Monoclonal Antibody Treatment" to help your patients understand how mAb treatment can help prevent more serious COVID-19 illness.

Download flyer

Informational Poster

Download an informational poster for your practice.

Download poster

Illustration of a doctor and a patient

CLINICAL EVIDENCE, GUIDELINES, AND VIDEOS

Clinical Evidence Summary

Read a summary of the clinical evidence and Emergency Use Authorizations (EUAs) for monoclonal antibodies.

Download summary

Science FAQs

Read a Provider FAQs document about the science.

Download provider FAQs

mAb Resources

Browse up-to-date resources for healthcare providers, including the April 2021 National Institutes of Health COVID-19 treatment guidelines, Centers for Disease Control and Prevention data on variants by state, EUA fact sheets, and more.

View page

mAb Videos

Hear from leading experts and watch a series on how to set up and manage infusion operations in your facility—from patient flow to safety to training.

Watch videos

COVID-19 CLINICAL TRIAL OPPORTUNITIES FOR YOUR PATIENTS

Find clinical trials for four patient categories: 1) Patients with COVID-19 who are not hospitalized; 2) Hospitalized COVID-19 patients; 3) Adults who have been exposed to COVID-19 but have not developed the disease; and 4) Adult patients who have been discharged from the hospital.

Explore clinical trials

MONOCLONAL ANTIBODY INFUSION LOCATIONS

Use our Therapeutics Distribution Locator to find outpatient facilities near you that have received shipments of mAb therapeutics.
 
 

Find infusion locations


PROMISING PRACTICES

The following documents provide promising practices and recommendations from provider organizations and states that have had success in increasing the utilization of COVID-19 monoclonal antibody treatments. These findings provide inspiration and information to those working to build treatment awareness and demand and can supplement individual plans and provide context to playbooks and planning discussions with leadership.


FDA PROVIDER FACT SHEETS

Learn more about the products the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to help Combat COVID-19.

Image
download icon

Bamlanivimab


PEER REVIEWED ARTICLES

Explore the following peer-reviewed articles that discuss a range of COVID-19 treatment topics.